Correlation Between Milestone Pharmaceuticals and Armata Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Armata Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Armata Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Armata Pharmaceuticals, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Armata Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Armata Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Armata Pharmaceuticals.
Diversification Opportunities for Milestone Pharmaceuticals and Armata Pharmaceuticals
-0.04 | Correlation Coefficient |
Good diversification
The 3 months correlation between Milestone and Armata is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Armata Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Armata Pharmaceuticals and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Armata Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Armata Pharmaceuticals has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Armata Pharmaceuticals go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and Armata Pharmaceuticals
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to generate 0.67 times more return on investment than Armata Pharmaceuticals. However, Milestone Pharmaceuticals is 1.49 times less risky than Armata Pharmaceuticals. It trades about 0.26 of its potential returns per unit of risk. Armata Pharmaceuticals is currently generating about -0.03 per unit of risk. If you would invest 147.00 in Milestone Pharmaceuticals on August 24, 2024 and sell it today you would earn a total of 38.00 from holding Milestone Pharmaceuticals or generate 25.85% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. Armata Pharmaceuticals
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| Armata Pharmaceuticals |
Milestone Pharmaceuticals and Armata Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and Armata Pharmaceuticals
The main advantage of trading using opposite Milestone Pharmaceuticals and Armata Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Armata Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Armata Pharmaceuticals will offset losses from the drop in Armata Pharmaceuticals' long position.The idea behind Milestone Pharmaceuticals and Armata Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |